(2R)-1-[1-[2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25-propan-2-yl-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]imidazole-4-carbonyl]pyrrolidine-2-carboxylic acid | 960062-08-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酰胺类
• 英文名称: (2R)-1-[1-[2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25-propan-2-yl-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]imidazole-4-carbonyl]pyrrolidine-2-carboxylic acid
• CAS: 960062-08-2
• 化学式: C₅₆H₅₃N₁₅O₁₀S₆
• 分子量: 1288.53
• InChiKey: KWVFIZBIRNPPSF-JXBGTQNESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  87
• 可旋转键数：
  11
• 环数：
  11.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  510
• 氢给体数：
  7
• 氢受体数：
  24

反应信息

• 作为产物：
  描述：

  在 sodium hydroxide 、 水 作用下， 以 甲醇 为溶剂， 反应 30.0h， 生成 (2R)-1-[1-[2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25-propan-2-yl-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]imidazole-4-carbonyl]pyrrolidine-2-carboxylic acid
  参考文献：
  名称：

  EFTU INHIBITORS OR AMINOTHIAZOLES AND THEIR USES

  摘要：

  本申请描述了对治疗、预防和/或改善疾病有用的有机化合物。

  公开号：

  US20080221142A1

文献信息

• AMINOTHIAZOLES AND THEIR USES
  申请人：LaMarche Matthew J.

  公开号：US20100267757A1

  公开（公告）日：2010-10-21

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.

  本申请描述了有机化合物，可用于治疗、预防和/或改善疾病。
• 4-Aminothiazolyl analogs of GE2270 A: Design, synthesis and evaluation of imidazole analogs
  作者：Matthew J. LaMarche、Jennifer A. Leeds、JoAnne Dzink-Fox、Steve Mullin、Michael A. Patane、Elin M. Rann、Stacey Tiamfook

  DOI：10.1016/j.bmcl.2011.04.048

  日期：2011.6

  Imidazole analogs of the antibiotic natural product GE2270 A (1) were designed, synthesized, and evaluated for Gram positive bacteria growth inhibition. A recently reported, copper-mediated synthesis was exploited to prepare 4-thiazolyl imidazole analogs of 1. The synthesis described represents a structurally complex, natural product-based application of this recently reported synthetic methodology. In addition, the biological evaluation of the imidazole-based analogs further define the SAR of the 4-aminothiazolyl-based antibacterial template. (C) 2011 Elsevier Ltd. All rights reserved.
• US7851439B2
  申请人：——

  公开号：US7851439B2

  公开（公告）日：2010-12-14
• EFTU INHIBITORS OR AMINOTHIAZOLES AND THEIR USES
  申请人：LaMarche Matthew J.

  公开号：US20080221142A1

  公开（公告）日：2008-09-11

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.

  本申请描述了对治疗、预防和/或改善疾病有用的有机化合物。